DK1407267T3 - Gelsammensætninger - Google Patents

Gelsammensætninger

Info

Publication number
DK1407267T3
DK1407267T3 DK02745605.2T DK02745605T DK1407267T3 DK 1407267 T3 DK1407267 T3 DK 1407267T3 DK 02745605 T DK02745605 T DK 02745605T DK 1407267 T3 DK1407267 T3 DK 1407267T3
Authority
DK
Denmark
Prior art keywords
gel
analyte
moieties
sol
entities
Prior art date
Application number
DK02745605.2T
Other languages
English (en)
Inventor
Margaret Joan Taylor
Original Assignee
Univ Montfort
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Montfort filed Critical Univ Montfort
Application granted granted Critical
Publication of DK1407267T3 publication Critical patent/DK1407267T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/558—Immunoassay; Biospecific binding assay; Materials therefor using diffusion or migration of antigen or antibody
    • G01N33/559—Immunoassay; Biospecific binding assay; Materials therefor using diffusion or migration of antigen or antibody through a gel, e.g. Ouchterlony technique
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/544—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being organic
    • G01N33/548—Carbohydrates, e.g. dextran
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
DK02745605.2T 2001-07-10 2002-07-10 Gelsammensætninger DK1407267T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0116860.8A GB0116860D0 (en) 2001-07-10 2001-07-10 Gel compositions
PCT/GB2002/003183 WO2003006993A2 (en) 2001-07-10 2002-07-10 Gel compositions

Publications (1)

Publication Number Publication Date
DK1407267T3 true DK1407267T3 (da) 2011-09-19

Family

ID=9918254

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02745605.2T DK1407267T3 (da) 2001-07-10 2002-07-10 Gelsammensætninger

Country Status (9)

Country Link
US (1) US8247391B2 (da)
EP (1) EP1407267B1 (da)
JP (2) JP2004534103A (da)
AT (1) ATE513214T1 (da)
DK (1) DK1407267T3 (da)
ES (1) ES2368036T3 (da)
GB (1) GB0116860D0 (da)
PT (1) PT1407267E (da)
WO (1) WO2003006993A2 (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0116860D0 (en) 2001-07-10 2001-09-05 Univ Montfort Gel compositions
DE10254636A1 (de) * 2002-11-22 2004-06-09 Capsulution Nanoscience Ag Verfahren zum Modifizieren von Mikropartikeln sowie Vorrichtung zum Modifizieren von Mikropartikeln
JP2008515434A (ja) * 2004-10-08 2008-05-15 ジョージア テック リサーチ コーポレイション 静電ポテンシャルを用いたヒドロゲル中の細胞のマイクロカプセル化
KR20110106440A (ko) * 2009-01-14 2011-09-28 코넬 유니버시티 생체의료 용도를 위한 생분해성 히드로겔의 제법
CN101745114B (zh) * 2009-12-25 2013-01-23 浙江工业大学 一种对葡萄糖敏感可自控释胰岛素的生物材料的制备方法
US20140350370A1 (en) * 2013-04-08 2014-11-27 The Texas A&M University System Glucose sensing assay
GB201310185D0 (en) 2013-06-07 2013-07-24 Univ Montfort Container
GB201314640D0 (en) * 2013-08-15 2013-10-02 Univ Montfort Matrix gel
MX2017013337A (es) 2015-04-21 2018-04-20 Univ North Carolina State Sistema de suministro de insulina sensible a la glucosa usando nanocompuestos sensibles a la hipoxia.
CN108366960B (zh) * 2015-10-23 2022-04-19 国立大学法人东京医科齿科大学 药物递送装置
WO2018085809A1 (en) 2016-11-07 2018-05-11 North Carolina State University Patch loaded with dual-sensitive vesicles for enhanced glucose-responsive insulin delivery
NO343313B1 (en) * 2017-03-15 2019-01-28 Lifecare As Fluid composition, method for preparing the composition and use
EP3899966A1 (en) * 2018-12-18 2021-10-27 Johnson & Johnson Consumer Inc. Personalized topical application patch

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4705503A (en) * 1986-02-03 1987-11-10 Regents Of The University Of Minnesota Metabolite sensor including a chemical concentration sensitive flow controller for a drug delivery system
GB9200638D0 (en) 1992-01-10 1992-03-11 Leicester Polytechnic Drug system
DE4203466A1 (de) * 1992-02-04 1993-08-05 Rudolf Prof Dr Ehwald Affinitaets-sensor
GB9313484D0 (en) 1993-06-30 1993-08-11 Univ Montfort Drug system ii
US5562917A (en) * 1994-12-23 1996-10-08 Pentech Pharmaceuticals, Inc. Transdermal administration of apomorphine
JP3536186B2 (ja) * 1995-02-27 2004-06-07 独立行政法人 科学技術振興機構 生体内分解性高分子ヒドロゲル
US5889028A (en) 1996-02-09 1999-03-30 Mayo Foundation For Medical Education And Research Colonic delivery of nicotine to treat inflammatory bowel disease
WO1998022097A2 (en) * 1996-11-20 1998-05-28 Bio Advances, Llc Controlled release matrix composition using polar polymer or monomer and poly(acrylic acid) blend
GB9805896D0 (en) 1998-03-20 1998-05-13 Eglise David Remote analysis system
ATE280588T1 (de) 1998-08-10 2004-11-15 Amgen Inc Dextran-leptin konjugate, pharmazeutische zusammentsetzungen und verbundene verfahren
JP2003517588A (ja) * 1999-08-27 2003-05-27 エム−バイオテック インコーポレイテッド グルコースバイオセンサ
GB0116860D0 (en) 2001-07-10 2001-09-05 Univ Montfort Gel compositions

Also Published As

Publication number Publication date
EP1407267B1 (en) 2011-06-15
EP1407267A2 (en) 2004-04-14
JP2004534103A (ja) 2004-11-11
US20040265386A1 (en) 2004-12-30
JP2011144197A (ja) 2011-07-28
JP5405511B2 (ja) 2014-02-05
PT1407267E (pt) 2011-09-19
WO2003006993A2 (en) 2003-01-23
US8247391B2 (en) 2012-08-21
ES2368036T3 (es) 2011-11-11
WO2003006993A3 (en) 2003-09-25
ATE513214T1 (de) 2011-07-15
GB0116860D0 (en) 2001-09-05

Similar Documents

Publication Publication Date Title
DK1407267T3 (da) Gelsammensætninger
FR14C0064I2 (fr) Anticorps anti-il-6, compositions, methodes et utilisations associees
NO20015096L (no) Måling og bruk av molekul¶re interaksjoner
MA27035A1 (fr) Ligands de recepteurs de 5-ht et leurs utilisations
DE50105338D1 (de) Neuartige polymerbindersysteme mit ionischen flüssigkeiten
BR0200472B1 (pt) composiÇço de fluido de hidrocarboneto lÍquido em forma de gel, e, agente de formaÇço de gel de lÍquido de hidrocarboneto.
ATE465748T1 (de) Vernetzte, nicht von pilzen kommende lipase enthaltende zusammensetzung und methoden zu deren verwendung
DE69810091D1 (de) Verwendung von interleukin-15
FR11C0053I2 (fr) Molecules ctla4 mutantes solubles et leurs utilisations
WO2002099597A3 (en) Method and system for providing context awareness
MXPA03008957A (es) Modulacion de interacciones de pd-1 con sus ligandos.
PT958277E (pt) Inibidores de oxido nitrico sintase
TR200102401T2 (tr) C-21 Değiştirilmiş epotilonlar.
DE50306232D1 (de) Ampholytisches copolymer und dessen verwendung
AU1628100A (en) Bidirectional lateral flow test strip and method
NO20021974L (no) Fargemerkede imidazokinolinforbindelser
NL1026030A1 (nl) Cannabino¤dreceptorliganden en toepassingen daarvan.
DE60115217D1 (de) Alprazolam inklusion-komplexe und ihre pharmazeutischen zusammensetzungen
FR2819410B1 (fr) Composition cosmetique irisee et ses utilisations
DE50206094D1 (de) Substituierte isoindole und ihre verwendung
TR200002987T2 (tr) Optik özelliklere sahip olan poli (Alkilen Arilatlar).
WO2002079980A3 (en) Software customisation
FR2819411B1 (fr) Composition cosmetique irisee et ses utilisations
DE50202730D1 (de) Substituierte isoindole und ihre verwendung
NO991105A1 (no) Bremseanordning for økning av motstandskoeffisient på ballistisk granat.